Current issue
Archive
Manuscripts accepted
About the Journal
Editorial office
Editorial board
Section Editors
Abstracting and indexing
Subscription
Contact
Ethical standards and procedures
Most read articles
Instructions for authors
Article Processing Charge (APC)
Regulations of paying article processing charge (APC)
RESEARCH LETTER
Diabetes risk assessment in Polish community pharmacies. Results from a pilot national screening campaign
1
Department of Biopharmacy, Medical University of Lodz, Poland
2
Pharmacy Practice and Pharmaceutical Care Division, Chair and Department of Pharmaceutical Technology, Poznan University of Medical Sciences, Poznan, Poland
3
Warsaw Pharmacy Chamber, Warsaw, Poland
4
Department of Internal Medicine and Diabetology, Poznan University of Medical Sciences, Poznan, Poland
5
Department of Family Medicine and Public Health, Institute of Medicine, University of Opole, Poland
These authors had equal contribution to this work
Submission date: 2025-09-12
Final revision date: 2025-11-21
Acceptance date: 2026-01-05
Online publication date: 2026-01-08
Corresponding author
Magdalena Jasińska-Stroschein
Department of Biopharmacy Medical University of Lodz Muszyńskiego 1 90-151 Lodz, Poland Phone +48 42 272 55 51
Department of Biopharmacy Medical University of Lodz Muszyńskiego 1 90-151 Lodz, Poland Phone +48 42 272 55 51
TOPICS
REFERENCES (22)
1.
GBD 2021 Causes of Death Collaborators. Global burden of 288 causes of death and life expectancy decomposition in 204 countries and territories and 811 subnational locations, 1990-2021: a systematic analysis for the Global Burden of Disease Study 2021. Lancet 2024; 403: 2100-32.
2.
Davies MJ, Aroda VR, Collins BS, et al. Management of hyperglycaemia in type 2 diabetes, 2022. A consensus report by the American Diabetes Association (ADA) and the European Association for the Study of Diabetes (EASD). Diabetologia 2022; 65: 1925-66.
3.
Tsuyuki RT, Beahm NP, Okada H, Al Hamarneh YN. Pharmacists as accessible primary health care providers: review of the evidence. Can Pharm J 2018; 151: 4-5.
4.
Chung WW, Chua SS, Lai PS, Chan SP. Effects of a pharmaceutical care model on medication adherence and glycemic control of people with type 2 diabetes. Patient Prefer Adherence 2014; 8: 1185-94.
5.
Brunetti P, Baldessin L, Pagliacci S. Prediabetes, undiagnosed diabetes and diabetes risk in Italy in 2017-2018: results from the first National screening campaign in community pharmacies. J Public Health (Oxf) 2022; 44: 499-506.
6.
Gargya D, Mirkazemi C, Curtain C. Qualitative exploration of the experiences of community pharmacists delivering the Diabetes MedsCheck service. J Clin Pharm Ther 2022; 47: 1194-200.
7.
Wright D, Little R, Turner D, Thornley T. Diabetes screening through community pharmacies in England: a cost-effectiveness study. Pharmacy 2019; 7: 30.
8.
Waszyk-Nowaczyk M, Jasińska-Stroschein M, Sierpniowska O, Jedra A. Guidelines for pharmacists on the procedure for measuring glucose concentration in capillary blood. Warsaw, 1 st Edition, 2025 available at https://nowy-lek.pl/ [2025, accessed 4 April 2025].
9.
Beaney T, Kerr GK, Kiru G, et al. May Measurement Month 2022: results from the global blood pressure screening campaign. BMJ Glob Health 2024; 9: e016557.
10.
Waszyk-Nowaczyk M, Guzenda W, Plewka B, et al. Screening services in a community pharmacy in Poznan (Poland) to increase early detection of hypertension. J Clin Med 2020; 9: 2572.
11.
Waszyk-Nowaczyk M, Jasińska-Stroschein M, Dymek J, et al. The critical role of community pharmacists in blood pressure monitoring. Med Sci Monit 2024; 30: e944657.
12.
Ciarambino T, Crispino P, Leto G, et al. Influence of gender in diabetes mellitus and its complication. Int J Mol Sci 2022; 23: 8850.
13.
Hiller J, Schatz K, Drexler H. Gender influence on health and risk behavior in primary prevention: a systematic review. Z Gesundh Wiss 2017; 25: 339-49.
14.
Twigg MJ, Wright DJ, Thornley T, Haynes L. Community pharmacy type 2 diabetes risk assessment: demographics and risk results. Int J Pharm Pract 2015; 23: 80-2.
15.
Iqbal MZ, Khan AH, Iqbal MS, Syed Sulaiman SA. A review of pharmacist-led interventions on diabetes outcomes: an observational analysis to explore diabetes care opportunities for pharmacists. J Pharm Bioallied Sci 2019; 11: 299-309.
16.
Orabone AW, Do V, Cohen E. Pharmacist-managed diabetes programs: improving treatment adherence and patient outcomes. Diabetes Metab Syndr Obes 2022; 15: 1911-23.
17.
Rahman M, Simmons RK, Hennings SH, Wareham NJ, Griffin SJ. How much does screening bring forward the diagnosis of type 2 diabetes and reduce complications? Twelve year follow-up of the Ely cohort. Diabetologia 2012; 55: 1651-9.
18.
Rondeaux S, Braeckman T, Beckwé M, et al. Diabetes and cardiovascular diseases risk assessment in community pharmacies: an implementation study. Int J Environ Res Public Health 2022; 19: 8699.
19.
Pagáčová Z, Grofik M, Fazekaš T, et al. Screening for diabetic peripheral neuropathy at community pharmacies in Slovakia. Croat Med J 2024; 65: 85-92.
20.
Jurić D, Pavličević I, Marušić A, et al. Effectiveness of treatment of newly diagnosed hypertension in family medicine practices in South Croatia. BMC Fam Pract 2019; 20: 10.
21.
Alzubaidi HT, Chandir S, Hasan S, et al. Diabetes and cardiovascular disease risk screening model in community pharmacies in a developing primary healthcare system: a feasibility study. BMJ Open 2019; 9: e031246.
22.
Willis A, Rivers P, Gray LJ, et al. The effectiveness of screening for diabetes and cardiovascular disease risk factors in a community pharmacy setting. PLoS One 2014; 9: e91157.
| eISSN: | 1896-9151 |
| ISSN: | 1734-1922 |
We process personal data collected when visiting the website. The function of obtaining information about users and their behavior is carried out by voluntarily entered information in forms and saving cookies in end devices. Data, including cookies, are used to provide services, improve the user experience and to analyze the traffic in accordance with the Privacy policy. Data are also collected and processed by Google Analytics tool (more).
You can change cookies settings in your browser. Restricted use of cookies in the browser configuration may affect some functionalities of the website.
You can change cookies settings in your browser. Restricted use of cookies in the browser configuration may affect some functionalities of the website.
